01 1Fagron Inc
01 1Dextrose Anhydrous
01 1Netherlands
NDC Package Code : 51552-0458
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-07-06
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
13
PharmaCompass offers a list of Glucose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glucose manufacturer or Glucose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glucose manufacturer or Glucose supplier.
PharmaCompass also assists you with knowing the Glucose API Price utilized in the formulation of products. Glucose API Price is not always fixed or binding as the Glucose Price is obtained through a variety of data sources. The Glucose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A glc manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of glc, including repackagers and relabelers. The FDA regulates glc manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. glc API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of glc manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A glc supplier is an individual or a company that provides glc active pharmaceutical ingredient (API) or glc finished formulations upon request. The glc suppliers may include glc API manufacturers, exporters, distributors and traders.
click here to find a list of glc suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing glc as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for glc API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture glc as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain glc and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a glc NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of glc suppliers with NDC on PharmaCompass.
